imatinib mesylate has been researched along with Hepatic Veno Occlusive Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decorti, G; Franca, R; Londero, M; Rabusin, M; Stocco, G; Verzegnassi, F | 1 |
| Dai, M; Fan, ZP; Huang, F; Jiang, QL; Li, XF; Liu, QF; Meng, FY; Shen, KF; Sun, J; Wang, HM; Wei, YQ; Xu, D; Yang, M; Zhang, Y; Zhou, HS | 1 |
1 review(s) available for imatinib mesylate and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Pharmacogenomic approaches for tailored anti-leukemic therapy in children.
Topics: Alkaloids; Antineoplastic Agents; Benzamides; Child; Glucocorticoids; Hepatic Veno-Occlusive Disease; Humans; Imatinib Mesylate; Mercaptopurine; Methotrexate; Nucleotides; Pharmacogenetics; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Thioguanine; Vincristine | 2013 |
1 other study(ies) available for imatinib mesylate and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
[Clinical analysis of acute heart failure's risk factor for chronic myelogenous leukemia patient during the early stage of allogeneic hematopoietic stem cell transplantation].
Topics: Acute Disease; Allografts; Antilymphocyte Serum; Benzamides; Heart Failure; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Imatinib Mesylate; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Retrospective Studies; Risk Factors | 2015 |